- Asano, Takaki
- Boisson, Bertrand
- Onodi, Fanny
- Matuozzo, Daniela
- Moncada-Velez, Marcela
- Maglorius Renkilaraj, Majistor Raj Luxman
- Zhang, Peng
- Meertens, Laurent
- Bolze, Alexandre
- Materna, Marie
- Korniotis, Sarantis
- Gervais, Adrian
- Talouarn, Estelle
- Bigio, Benedetta
- Seeleuthner, Yoann
- Bilguvar, Kaya
- Zhang, Yu
- Neehus, Anna-Lena
- Ogishi, Masato
- Pelham, Simon J.
- Le Voyer, Tom
- Rosain, Jérémie
- Philippot, Quentin
- Soler-Palacín, Pere
- Colobran, Roger
- Martin-Nalda, Andrea
- Rivière, Jacques G.
- Tandjaoui-Lambiotte, Yacine
- Chaïbi, Khalil
- Shahrooei, Mohammad
- Darazam, Ilad Alavi
- Olyaei, Nasrin Alipour
- Mansouri, Davood
- Hatipoğlu, Nevin
- Palabiyik, Figen
- Ozcelik, Tayfun
- Novelli, Giuseppe
- Novelli, Antonio
- Casari, Giorgio
- Aiuti, Alessandro
- Carrera, Paola
- Bondesan, Simone
- Barzaghi, Federica
- Rovere-Querini, Patrizia
- Tresoldi, Cristina
- Franco, Jose Luis
- Rojas, Julian
- Reyes, Luis Felipe
- Bustos, Ingrid G.
- Arias, Andres Augusto
- Morelle, Guillaume
- Christèle, Kyheng
- Troya, Jesús
- Planas-Serra, Laura
- Schlüter, Agatha
- Gut, Marta
- Pujol, Aurora
- Allende, Luis M.
- Rodriguez-Gallego, Carlos
- Flores, Carlos
- Cabrera-Marante, Oscar
- Pleguezuelo, Daniel E.
- Pérez de Diego, Rebeca
- Keles, Sevgi
- Aytekin, Gokhan
- Akcan, Ozge Metin
- Bryceson, Yenan T.
- Bergman, Peter
- Brodin, Petter
- Smole, Daniel
- Smith, C. I. Edvard
- Norlin, Anna-Carin
- Campbell, Tessa M.
- Covill, Laura E.
- Hammarström, Lennart
- Pan-Hammarström, Qiang
- Abolhassani, Hassan
- Mane, Shrikant
- Marr, Nico
- Ata, Manar
- Al Ali, Fatima
- Khan, Taushif
- Spaan, András N.
- Dalgard, Clifton L.
- Bonfanti, Paolo
- Biondi, Andrea
- Tubiana, Sarah
- Burdet, Charles
- Nussbaum, Robert
- Kahn-Kirby, Amanda
- Snow, Andrew L.
- Bustamante, Jacinta
- Puel, Anne
- Boisson-Dupuis, Stéphanie
- Zhang, Shen-Ying
- Béziat, Vivien
- Lifton, Richard P.
- Bastard, Paul
- Notarangelo, Luigi D.
- Abel, Laurent
- Su, Helen C.
- Jouanguy, Emmanuelle
- Amara, Ali
- Soumelis, Vassili
- Cobat, Aurélie
- Zhang, Qian
- Casanova, Jean-Laurent
Members of COVID Human Genetic Effort: Laurent Abel1, Alessandro Aiuti2, Saleh Al-Muhsen3, Fahd Al-Mulla4, Mark S. Anderson5, Evangelos Andreakos6, Andrés A. Arias7, Hagit Baris Feldman8, Alexandre Belot9, Catherine M. Biggs10, Dusan Bogunovic11, Alexandre Bolze12, Anastasiia Bondarenko13, Ahmed A. Bousfiha14, Petter Brodin15, Yenan Bryceson16, Carlos D. Bustamante17, Manish J. Butte18, Giorgio Casari19, Samya Chakravorty20, John Christodoulou21, Antonio Condino-Neto22, Stefan N. Constantinescu23, Megan A. Cooper24, Clifton L. Dalgard25, Murkesh Desai26, Beth A. Drolet27, Jamila El Baghdadi28, Sara Espinosa-Padilla29, Jacques Fellay30, Carlos Flores31, José Luis Franco7, Antoine Froidure32, Peter K. Gregersen33, Filomeen Haerynck34, David Hagin35, Rabih Halwani36, Lennart Hammarström37, James R. Heath38, Sarah E. Henrickson39, Elena W. Y. Hsieh40, Eystein Husebye41, Kohsuke Imai42, Yuval Itan43, Erich D. Jarvis44, Timokratis Karamitros45, Kai Kisand46, Cheng-Lung Ku47, Yu-Lung Lau48, Yun Ling49, Carrie L. Lucas50, Tom Maniatis51, Davood Mansouri52, László Maródi53, Isabelle Meyts54, Joshua D. Milner55, Kristina Mironska56, Trine H. Mogensen57, Tomohiro Morio58, Lisa F. P. Ng59, Luigi D. Notarangelo60, Antonio Novelli61, Giuseppe Novelli62, Cliona O’Farrelly63, Satoshi Okada64, Tayfun Ozcelik65, Qiang Pan-Hammarström37, Rebeca Perez de Diego66, Anna M. Planas67, Carolina Prando68, Aurora Pujol69, Lluis Quintana-Murci70, Laurent Renia59, Igor Resnick71, Carlos Rodríguez-Gallego72, Vanessa Sancho-Shimizu73, Anna Sediva74, Mikko R. J. Seppänen75, Mohammed Shahrooei76, Anna Shcherbina77, Ondrej Slaby78, Andrew L. Snow79, Pere Soler-Palacín80, András N. Spaan81, Ivan Tancevski82, Stuart G. Tangye83, Ahmad Abou Tayoun84, Sathishkumar Ramaswamy84, Stuart E. Turvey85, Furkan Uddin86, Mohammed J. Uddin87, Diederik van de Beek88, Donald C. Vinh89, Horst von Bernuth90, Mayana Zatz91, Pawel Zawadzki92, Helen C. Su60, Jean-Laurent Casanova93, Autosomal inborn errors of type I IFN immunity and autoantibodies against these cytokines underlie at least 10% of critical COVID-19 pneumonia cases. We report very rare, biochemically deleterious X-linked TLR7 variants in 16 unrelated male individuals aged 7 to 71 years (mean: 36.7 years) from a cohort of 1,202 male patients aged 0.5 to 99 years (mean: 52.9 years) with unexplained critical COVID-19 pneumonia. None of the 331 asymptomatically or mildly infected male individuals aged 1.3 to 102 years (mean: 38.7 years) tested carry such TLR7 variants (p = 3.5 × 10-5). The phenotypes of five hemizygous relatives of index cases infected with SARS-CoV-2 include asymptomatic or mild infection (n=2, 5 and 38 years), or moderate (n=1, 5 years), severe (n=1, 27 years), or critical (n=1, 29 years) pneumonia. Two boys (aged 7 and 12 years) from a cohort of 262 male patients with severe COVID-19 pneumonia (mean: 51.0 years) are hemizygous for a deleterious TLR7 variant. The cumulative allele frequency for deleterious TLR7 variants in the male general population is < 6.5x10-4 We also show that blood B cell lines and myeloid cell subsets from the patients do not respond to TLR7 stimulation, a phenotype rescued by wild-type TLR7 The patients' blood plasmacytoid dendritic cells (pDCs) produce low levels of type I IFNs in response to SARS-CoV-2. Overall, X-linked recessive TLR7 deficiency is a highly penetrant genetic etiology of critical COVID-19 pneumonia, in about 1.8% of male patients below the age of 60 years. Human TLR7 and pDCs are essential for protective type I IFN immunity against SARS-CoV-2 in the respiratory tract., The Laboratory of Human Genetics of
Infectious Diseases is supported by the Howard Hughes Medical Institute, Rockefeller
University; the St. Giles Foundation; the NIH (R01AI088364), the National Center for Advancing
Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program
(UL1TR001866); a Fast Grant from Emergent Ventures; Mercatus Center at the George Mason
University; the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded
by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and
U24HG008956); the Fisher Center for Alzheimer’s Research Foundation; the Meyer Foundation;
the JPB Foundation; the French National Research Agency (ANR) under the “Investments for
the Future” program (ANR-10-IAHU-01) and the Integrative Biology of Emerging Infectious
Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID); the French Foundation for Medical
Research (FRM) (EQU201903007798); the FRM and ANR GENCOVID project, the ANRS-COV05,
ANR GENVIR (ANR-20-CE93-003), and ANR AABIFNCOV (ANR-20-CO11-0001) projects; the
European Union’s Horizon 2020 Research and Innovation Program under grant agreement no.
824110 (EASI-genomics); the Square Foundation; Grandir–Fonds de solidarité pour l’enfance;
the SCOR Corporate Foundation for Science; Fondation du Souffle; Institut National de la Santé
et de la Recherche Médicale (INSERM); REACTing-INSERM; and the University of Paris. The
French COVID Cohort study group was sponsored by INSERM and supported by the REACTing
consortium and by a grant from the French Ministry of Health (PHRC 20-0424). The
Cov-Contact Cohort was supported by the REACTing consortium, the French Ministry of
Health, and the European Commission (RECOVER WP 6). The Neurometabolic Diseases
Laboratory received funding from the European Union’s Horizon 2020 Research and
Innovation Program (EasiGenomics grant no. 824110 COVID-19/PID12342). A.P., R.P.d.D.,
C.R.-G., and C.F. were funded by Instituto de Salud Carlos III (COV20_01333 and COV20_01334),
the Spanish Ministry of Science and Innovation (RTC-2017-6471-1; AEI/FEDER, UE), Fundación
DISA (OA18/017), and Cabildo Insular de Tenerife (CGIEU0000219140 and “Apuestas científicas
del ITER para colaborar en la lucha contra la COVID-19”). The laboratories of G.N. and A.N. were
supported by a grant awarded to Regione Lazio (PROGETTI DI GRUPPI DI RICERCA 2020) no.
A0375-2020-36663, GecoBiomark. A. Amara’s laboratory was supported by ANR under the
“Investments for the Future” program (ANR-10-IAHU-01), the Integrative Biology of Emerging
Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the FRM
(EQU202003010193), ANR (ANR-20-COVI-000 project IDISCOVR and ANR-20-CO11-0004
project FISHBP), and the University of Paris (Plan de Soutien Covid-19: RACPL20FIR01-COVIDSOUL).
This work was supported, in part, by the Division of Intramural Research, NIAID, NIH
(grants 1ZIAAI001265 to H.C.S. and ZIA AI001270 to L.D.N.). The G.C. laboratory was supported
by the Italian Ministry of Health (grant COVID-2020-12371617) and the intramural COVID Host
Genetics program. The J.L.F. laboratory was supported, in part, by the Coopération
Scientifique France-Colciencias (ECOS-Nord/COLCIENCIAS/MEN/ICETEX; 806-2018) and
Colciencias contract 713-2016 (no. 111574455633). The V.S. laboratory was supported by ANR
DENDRISEPSIS (ANR-17-CE15-0003) and ANR APCOD (ANR-17-CE15-0003-01), a Fast Grant
from the Mercatus Center, FRM, University of Paris PLAN D’URGENCE COVID19. The N.M.
laboratory was supported by Sidra Medicine (SDR400048) and the Qatar National Research
Fund (grant No. NPRP9-251-3-045). A.-L.N. was supported by the Bettencourt Schueller
Foundation and the International PhD program of the Imagine Institute. P. Bergman and C.I.E.S
received support from the Center for Medical Innovation (CIMED), the Swedish Medical
Research Council and the Stockholm County Council (ALF-project). Part of this work was
generated within the European Reference Network for rare primary immunodeficiency,
autoinflammatory and autoimmune diseases (RITA). Author contributions: A.K.-K., A. Amara,
A.C., A.G., A.-L.N., A. Puel, B. Boisson, E.J., F.A.A., F.O., J.B., J. Rosain, L.M., M.A., M.M.-V., M.M.,
M.O., M.R.L.M.R., N.M., P. Bastard, Q.P., Q.Z., S.B.-D., S.J.P., S. Korniotis, S.M., T.A., T.K., T.L.V., V.B.,
V.S., P.Z., S.-Y.Z., and Y.Z. performed or supervised experiments, generated and analyzed data,
and contributed to the manuscript by providing figures and tables. A.C., A. Bolze, A. Pujol,
B. Bigio, D. Matuozzo, K.B., L.A., and Y.S. performed computational analyses of data. A. Aiuti,
A.A.A., A. Biondi, A.-C.N., A.L.S., A.M.-N., A.N., A.N.S., A.S., A. Pujol, C.B., C.F., C.K., C.L.D., C.T.,
D.E.P., D. Mansouri, D.S., E.J., C.I.E.S., F.B., F.P., G.A., G.C., G.M., G.N., H.A., H.C.S., I.A.D., I.G.B.,
J.C.R.G., J.G.R., J.L.F., J. Rojas, J.T., K.C., L.F.R., L.E.C., L.H., L.D.N., L.P.-S., M.G., L.M.A., M.S., N.A.O.,
N.H., O.C.-M., O.M.A., P. Bergman, P. Brodin, P.C., P.R.-Q., P.S.-P., P. Bastard, P. Bonfanti, Q.P.-H.,
Q.Z., R.C., R.N., R.P.d.D., R.P.L., S.A., S.B., S.T., S. Keles, T.M.C., T.O., Y.T.B., and Y.T.-L. evaluated and
recruited patients to the COVID and/or control cohorts. B. Boisson, Q.Z., A.C., L.A. and J.-L.C.
wrote the manuscript. All the authors edited the manuscript. J.-L.C. supervised the project, Peer reviewed